Cargando…
Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients—A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime
SIMPLE SUMMARY: All initial therapeutic decisions in early breast cancer are commonly based on the intrinsic subtype consisting of estrogen (ER), progesterone (PR), the human epidermal growth factor 2 (HER2) receptors and the proliferation marker Ki67. However, breast cancer is a very heterogeneous...
Autores principales: | Weydandt, Laura, Nel, Ivonne, Kreklau, Anne, Horn, Lars-Christian, Aktas, Bahriye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024720/ https://www.ncbi.nlm.nih.gov/pubmed/35454772 http://dx.doi.org/10.3390/cancers14081863 |
Ejemplares similares
-
Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors
por: König, Theresa, et al.
Publicado: (2023) -
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016) -
Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision
por: Georgescu, Rares, et al.
Publicado: (2018) -
Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype
por: Wolf, Benjamin, et al.
Publicado: (2023) -
Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases
por: Xi, Xun, et al.
Publicado: (2020)